SYNTHESIS OF THE POTENT NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR CI-907 AND CERTAIN OF ITS ISOMERS AND ANALOGS

被引：0
|
作者：
BLANKLEY, CJ [1 ]
KALTENBRONN, JS [1 ]
DEJOHN, DE [1 ]
WERNER, A [1 ]
BENNETT, LR [1 ]
BOBOWSKI, G [1 ]
HOEFLE, ML [1 ]
ESSENBURG, A [1 ]
PEARLMAN, WM [1 ]
KAPLAN, HR [1 ]
机构：
[1] WARNER LAMBERT PARKE DAVIS,DIV PHARMACEUT RES,ANN ARBOR,MI 48106
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1983年 / 185卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：66 / MEDI
相关论文
共 50 条
  • [31] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF PENTAPEPTIDE ANALOGS OF THE POTENT ANGIOTENSIN CONVERTING ENZYME-INHIBITOR 5(S)-BENZAMIDO-4-OXO-6-PHENYLHEXANOYL-L-PROLINE
    ALMQUIST, RG
    JENNINGSWHITE, C
    CHAO, WR
    STEEGER, T
    WHEELER, K
    ROGERS, J
    MITOMA, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (08) : 1062 - 1066
  • [32] ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421
    GAVRAS, H
    WAEBER, B
    GAVRAS, I
    BIOLLAZ, J
    BRUNNER, HR
    DAVIES, RO
    LANCET, 1981, 2 (8246): : 543 - 547
  • [33] RADIOIMMUNOASSAYS FOR A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ZABICIPRIL, AND ITS ACTIVE METABOLITE, ZABICIPRILAT, IN HUMAN PLASMA
    LELIEVRE, E
    CARDONA, H
    BRILLANCEAU, MH
    PIRAUBE, C
    SAUVEUR, C
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (11) : 1065 - 1070
  • [34] ENZYME IMMUNOASSAYS FOR A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ZABICIPRIL, AND ITS ACTIVE METABOLITE IN HUMAN PLASMA - APPLICATION TO PHARMACOKINETIC STUDIES
    EZAN, E
    MORGE, X
    LELIEVRE, E
    CREMINON, C
    PIRAUBE, C
    GROGNET, JM
    THERAPEUTIC DRUG MONITORING, 1993, 15 (05) : 448 - 454
  • [35] CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, CAPTOPRIL
    FERGUSON, RK
    VLASSES, PH
    AMERICAN HEART JOURNAL, 1981, 101 (05) : 650 - 656
  • [36] PHARMACOLOGICAL STUDIES ON SA446, A NEW ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR
    ISO, T
    YAMAUCHI, H
    SUDA, H
    NAKAJIMA, N
    NISHIMURA, K
    TAKADA, T
    HORIUCHI, M
    NAKATA, K
    IWAO, J
    JAPANESE JOURNAL OF PHARMACOLOGY, 1980, 30 : P136 - P136
  • [37] EFFECTS OF THE NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, RAMIPRIL, IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    STUMPE, KO
    OVERLACK, A
    KOLLOCH, R
    SCHATZ, J
    WITTE, PU
    PAHNKE, K
    KLINISCHE WOCHENSCHRIFT, 1986, 64 (12): : 558 - 562
  • [38] EFFECT OF CILAZAPRIL, A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, ON RENAL HEMODYNAMICS, PROSTAGLANDIN AND ELECTROLYTE EXCRETION
    PASSMORE, AP
    KONDOWE, GB
    JOHNSTON, GD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 198 - 198
  • [39] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    DAVIES, RO
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) : 303 - 314
  • [40] CGS-13945 - A NEW ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN NORMAL VOLUNTEERS
    DESCOMBES, BJ
    TURINI, GA
    BRUNNER, HR
    PORCHET, M
    CHEN, DS
    SEN, SB
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (04) : 511 - 516
12345